1. NUCKS1 Acts as a Promising Novel Biomarker for the Prognosis of Patients with Hepatocellular Carcinoma
   Xianfeng Zhang et al, 2023, Cancer Biotherapy and Radiopharmaceuticals CrossRef
2. Phenylpropanoids from Juglans mandshurica exhibit cytotoxicities on liver cancer cell lines through apoptosis induction
   Zhuo-Yang Cheng et al, 2017, Bioorganic & Medicinal Chemistry Letters CrossRef
3. Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort
   Yvonne Huber et al, 2018, BMC Cancer CrossRef
4. Insulin-Like Growth Factor (IGF) System in Liver Diseases
   Agnieszka Adamek et al, 2018, International Journal of Molecular Sciences CrossRef
5. Tumor Biomarkers and Interventional Oncology: Impact on Local Outcomes for Liver and Lung Malignancy
   Yuan-Mao Lin et al, 2021, Current Oncology Reports CrossRef
6. The status of transarterial chemoembolization treatment in the era of precision oncology
   Valerie Fako et al, 2017, Hepatic Oncology CrossRef
7. Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis
   Jing Wang et al, 2017, Oncotarget CrossRef
8. Preoperative Serum Insulin-Like Growth Factor 1 Level as a Prognostic Factor in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma
   Lan Shen et al, 2018, Journal of Interferon & Cytokine Research CrossRef
9. Insulin-like growth factor (IGF) axis in cancerogenesis
   Aldona Kasprzak et al, 2017, Mutation Research/Reviews in Mutation Research CrossRef
10. Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients
    Reham Abdel-Wahab et al, 2020, Oncology CrossRef